CN108841949B - 帕金森病早期检测和诊断试剂盒及装置 - Google Patents
帕金森病早期检测和诊断试剂盒及装置 Download PDFInfo
- Publication number
- CN108841949B CN108841949B CN201810753754.2A CN201810753754A CN108841949B CN 108841949 B CN108841949 B CN 108841949B CN 201810753754 A CN201810753754 A CN 201810753754A CN 108841949 B CN108841949 B CN 108841949B
- Authority
- CN
- China
- Prior art keywords
- gene
- detecting
- seq
- chchd2
- ahsp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000018737 Parkinson disease Diseases 0.000 title claims abstract description 70
- 238000001514 detection method Methods 0.000 title claims abstract description 43
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 27
- 238000003745 diagnosis Methods 0.000 title claims abstract description 24
- 230000014509 gene expression Effects 0.000 claims abstract description 58
- 210000003743 erythrocyte Anatomy 0.000 claims abstract description 45
- 101150055789 CHCHD2 gene Proteins 0.000 claims abstract description 31
- 101100167060 Homo sapiens CHCHD2 gene Proteins 0.000 claims abstract description 31
- 239000000523 sample Substances 0.000 claims description 57
- 108090000623 proteins and genes Proteins 0.000 claims description 40
- 101150028074 2 gene Proteins 0.000 claims description 27
- 101150078398 Ahsp gene Proteins 0.000 claims description 24
- 101000797984 Homo sapiens Alpha-hemoglobin-stabilizing protein Proteins 0.000 claims description 16
- 238000007847 digital PCR Methods 0.000 claims description 16
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 14
- 108020004999 messenger RNA Proteins 0.000 claims description 10
- 238000011529 RT qPCR Methods 0.000 claims description 7
- 238000003757 reverse transcription PCR Methods 0.000 claims description 7
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 6
- 238000007901 in situ hybridization Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 150000007523 nucleic acids Chemical group 0.000 claims description 6
- 238000002123 RNA extraction Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 239000003381 stabilizer Substances 0.000 claims description 5
- 102100034343 Integrase Human genes 0.000 claims description 4
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 4
- 239000000872 buffer Substances 0.000 claims description 4
- 230000003321 amplification Effects 0.000 claims description 3
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 3
- 238000011895 specific detection Methods 0.000 claims 2
- 238000009007 Diagnostic Kit Methods 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 18
- 239000008280 blood Substances 0.000 abstract description 18
- 238000000605 extraction Methods 0.000 abstract description 10
- 238000007405 data analysis Methods 0.000 abstract description 7
- 238000013399 early diagnosis Methods 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 3
- 238000000034 method Methods 0.000 description 21
- 102000004169 proteins and genes Human genes 0.000 description 15
- 102100032381 Alpha-hemoglobin-stabilizing protein Human genes 0.000 description 13
- 239000002773 nucleotide Substances 0.000 description 13
- 125000003729 nucleotide group Chemical group 0.000 description 13
- 102100023692 Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 Human genes 0.000 description 11
- 101000906986 Homo sapiens Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 Proteins 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 9
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 9
- 239000000090 biomarker Substances 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000011144 upstream manufacturing Methods 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 238000003753 real-time PCR Methods 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 102100026882 Alpha-synuclein Human genes 0.000 description 2
- 206010061818 Disease progression Diseases 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 230000005750 disease progression Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000012165 high-throughput sequencing Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000012474 protein marker Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 102100037991 85/88 kDa calcium-independent phospholipase A2 Human genes 0.000 description 1
- 101150037123 APOE gene Proteins 0.000 description 1
- 102100029470 Apolipoprotein E Human genes 0.000 description 1
- 102100022207 E3 ubiquitin-protein ligase parkin Human genes 0.000 description 1
- 102100031690 Erythroid transcription factor Human genes 0.000 description 1
- 102100039735 Eukaryotic translation initiation factor 4 gamma 1 Human genes 0.000 description 1
- 102100029525 F-box only protein 7 Human genes 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 101000834898 Homo sapiens Alpha-synuclein Proteins 0.000 description 1
- 101000619542 Homo sapiens E3 ubiquitin-protein ligase parkin Proteins 0.000 description 1
- 101001066268 Homo sapiens Erythroid transcription factor Proteins 0.000 description 1
- 101001034825 Homo sapiens Eukaryotic translation initiation factor 4 gamma 1 Proteins 0.000 description 1
- 101000917536 Homo sapiens F-box only protein 7 Proteins 0.000 description 1
- 101000891579 Homo sapiens Microtubule-associated protein tau Proteins 0.000 description 1
- 101000887201 Homo sapiens Polyamine-transporting ATPase 13A2 Proteins 0.000 description 1
- 101000617536 Homo sapiens Presenilin-1 Proteins 0.000 description 1
- 101000617546 Homo sapiens Presenilin-2 Proteins 0.000 description 1
- 101000605835 Homo sapiens Serine/threonine-protein kinase PINK1, mitochondrial Proteins 0.000 description 1
- 101000617808 Homo sapiens Synphilin-1 Proteins 0.000 description 1
- 101000854862 Homo sapiens Vacuolar protein sorting-associated protein 35 Proteins 0.000 description 1
- 108010020246 Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 Proteins 0.000 description 1
- 102100032693 Leucine-rich repeat serine/threonine-protein kinase 2 Human genes 0.000 description 1
- 102100040243 Microtubule-associated protein tau Human genes 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 101710125553 PLA2G6 Proteins 0.000 description 1
- 102100039917 Polyamine-transporting ATPase 13A2 Human genes 0.000 description 1
- 102100022033 Presenilin-1 Human genes 0.000 description 1
- 102100022036 Presenilin-2 Human genes 0.000 description 1
- 102000007659 Protein Deglycase DJ-1 Human genes 0.000 description 1
- 108010032428 Protein Deglycase DJ-1 Proteins 0.000 description 1
- 102100038376 Serine/threonine-protein kinase PINK1, mitochondrial Human genes 0.000 description 1
- 102100021997 Synphilin-1 Human genes 0.000 description 1
- 102100022563 Tubulin polymerization-promoting protein Human genes 0.000 description 1
- 101710158555 Tubulin polymerization-promoting protein Proteins 0.000 description 1
- 102000005918 Ubiquitin Thiolesterase Human genes 0.000 description 1
- 108010005656 Ubiquitin Thiolesterase Proteins 0.000 description 1
- 102100020822 Vacuolar protein sorting-associated protein 35 Human genes 0.000 description 1
- 108090000185 alpha-Synuclein Proteins 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000006999 cognitive decline Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010252 digital analysis Methods 0.000 description 1
- 210000004002 dopaminergic cell Anatomy 0.000 description 1
- 210000005064 dopaminergic neuron Anatomy 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- 238000011223 gene expression profiling Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000002796 luminescence method Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 238000010984 neurological examination Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000010837 poor prognosis Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000001144 postural effect Effects 0.000 description 1
- 238000002331 protein detection Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Abstract
Description
SuperScript<sup>TM</sup>III RT逆转录酶/Platinum<sup>TM</sup>Taq酶混合物 | |
2X mix buffer | 含0.2mM dNTPs,3mM MgS0<sub>4</sub> |
CHCHD2探针 | 200nM |
CHCHD2上、下游引物对 | 各500nM |
AHSP探针 | 200nM |
AHSP上、下游引物对 | 各500nM |
液滴稳定剂 | 1x |
H<sub>2</sub>O |
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810753754.2A CN108841949B (zh) | 2018-07-10 | 2018-07-10 | 帕金森病早期检测和诊断试剂盒及装置 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810753754.2A CN108841949B (zh) | 2018-07-10 | 2018-07-10 | 帕金森病早期检测和诊断试剂盒及装置 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108841949A CN108841949A (zh) | 2018-11-20 |
CN108841949B true CN108841949B (zh) | 2021-03-02 |
Family
ID=64196078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810753754.2A Active CN108841949B (zh) | 2018-07-10 | 2018-07-10 | 帕金森病早期检测和诊断试剂盒及装置 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108841949B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111454960B (zh) * | 2020-04-10 | 2022-02-15 | 四川大学华西医院 | 一种检测帕金森病的诊断试剂盒 |
CN112522425B (zh) * | 2020-12-25 | 2023-11-28 | 武汉睿健医药科技有限公司 | Dpc细胞鉴定分类用标记物基因、筛选方法及应用 |
CN115029428B (zh) * | 2022-05-27 | 2023-08-15 | 四川省医学科学院·四川省人民医院 | 基于口腔黏膜pink1基因的颞下颌关节骨关节病辅助诊断、预后评价试剂盒及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016086787A (ja) * | 2014-11-11 | 2016-05-23 | 学校法人順天堂 | パーキンソン病の診断 |
CN107419008A (zh) * | 2017-06-26 | 2017-12-01 | 上海惠皓医疗科技有限公司 | 一种早期精确诊断帕金森病的方法和试剂盒 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9970056B2 (en) * | 2015-02-25 | 2018-05-15 | Rosalind Franklin University Of Medicine And Science | Methods and kits for diagnosing, prognosing and monitoring parkinson's disease |
-
2018
- 2018-07-10 CN CN201810753754.2A patent/CN108841949B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016086787A (ja) * | 2014-11-11 | 2016-05-23 | 学校法人順天堂 | パーキンソン病の診断 |
CN107419008A (zh) * | 2017-06-26 | 2017-12-01 | 上海惠皓医疗科技有限公司 | 一种早期精确诊断帕金森病的方法和试剂盒 |
Non-Patent Citations (2)
Title |
---|
CHCHD2 mutations in autosomal dominant late-onset Parkinsons disease: a genome-wide linkage and sequencing study;Manabu Funayama等;《The Lancet Neurology》;20150331;第14卷(第3期);274-282 * |
Loss of Parkinsons disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c;Hongrui Meng等;《NATURE COMMUNICATIONS》;20170607;摘要 * |
Also Published As
Publication number | Publication date |
---|---|
CN108841949A (zh) | 2018-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7413455B2 (ja) | 外傷性脳傷害のバイオマーカー | |
US20200332361A1 (en) | Method for assisting detection of alzheimer's disease or mild cognitive impairment | |
BR112013033488B1 (pt) | Métodos para facilitar o diagnóstico do comprometimento cognitivo devido a doença de alzheimer ou comprometimento cognitivo leve (mci)e kit | |
CN108841949B (zh) | 帕金森病早期检测和诊断试剂盒及装置 | |
CN112481379B (zh) | 一种检测Ph样ALL融合基因的引物探针组合与试剂盒 | |
KR20180044220A (ko) | miRNA 기반의 인지장애 질환 진단용 조성물 및 방법 | |
JP7394441B2 (ja) | 脳腫瘍を検査する方法 | |
CN112522391A (zh) | hsa_circ_0008961作为痛风诊断标志物的应用 | |
EP3438281A1 (en) | Stress biomarker | |
RU2771757C2 (ru) | Биомаркеры травматического повреждения головного мозга | |
EP3369829B1 (en) | Methods for detecting attention-deficit/hyperactivity disorder | |
CN108277268B (zh) | 用于诊断精神分裂症的外周血标志物-血浆游离dna | |
CN112458165A (zh) | 一种阿尔茨海默病的预测标志物、检测试剂盒及应用 | |
CN113355410A (zh) | 一种原发性痛风诊断标志物及应用 | |
CN116064768A (zh) | 视神经脊髓炎谱系疾病相关性视神经炎诊断分子标记物circRNA试剂盒及应用 | |
TW202305146A (zh) | 利用微小核醣核酸檢測合併乾癬性關節炎及僵直性脊椎炎之血清陰性關節炎風險與發炎性腸炎引起的相關性背痛風險的方法及其應用 | |
EP2687607A1 (en) | MicroRNA profiles in the diagnosis of multiple sclerosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Xiaodan Inventor after: Wang Qilong Inventor before: Zhang Jing Inventor before: Liu Xiaodan Inventor before: Wang Qilong |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231107 Address after: 17th Floor, Block B, Cambridge Commune, No. 789 Shenhua Road, Xihu District, Hangzhou City, Zhejiang Province, 310012 Patentee after: Zhejiang Bauhinia Biotechnology Co.,Ltd. Address before: 100871 No. 5, the Summer Palace Road, Beijing, Haidian District Patentee before: Peking University |
|
TR01 | Transfer of patent right |